Twenty-four-week efficacy and resistance profile of a zidovudine/lamivudine/tenofovir DF combination therapy in antiretroviral-naive patients

被引：0
|
作者：
Masquelier, B
Neau, D
Boucher, S
Lavignolle-Aurillac, V
Schrive, MH
Recordon-Pinson, P
Ragnaud, JM
Fleury, H
机构：
[1] Bordeaux Univ Hosp, Bordeaux, France
[2] INSERM, U593, Bordeaux, France
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
020
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Twenty-four-week efficacy and resistance profile of a zidovudine/lamivudine/tenofovir DF combination therapy in antiretroviral-naive patients
    Masquelier, B
    Neau, D
    Boucher, S
    Lavignolle-Aurillac, V
    Schrive, MH
    Recordon-Pinson, P
    Ragnaud, JM
    Fleury, H
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S22 - S22
  • [2] Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients
    Masquelier, Bernard
    Neau, Didier
    Boucher, Sebastien
    Lavignolle-Aurillac, Valerie
    Schrive, Marie-Helene
    Recordon-Pinson, Patricia
    Ragnaud, Jean-Marie
    Fleury, Herve
    [J]. ANTIVIRAL THERAPY, 2006, 11 (06) : 827 - 830
  • [3] Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe
    Swartz, J. E.
    Vandekerckhove, L.
    Ammerlaan, H.
    de Vries, A. C.
    Begovac, J.
    Bierman, W. F. W.
    Boucher, C. A. B.
    van der Ende, M. E.
    Grossman, Z.
    Kaiser, R.
    Levy, I.
    Mudrikova, T.
    Paredes, R.
    Perez-Bercoff, D.
    Pronk, M.
    Richter, C.
    Schmit, J. C.
    Vercauteren, J.
    Zazzi, M.
    Lepej, S. Zidovec
    De Luca, A.
    Wensing, A. M. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) : 1850 - 1857
  • [4] Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients - A randomized controlled comparison with zidovudine monotherapy
    Katlama, C
    Ingrand, D
    Loveday, C
    Clumeck, N
    Mallolas, J
    Staszewski, S
    Johnson, M
    Hill, AM
    Pearce, G
    McDade, H
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 118 - 125
  • [5] Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive patients
    White, Kirsten L.
    Kulkarni, Rima
    McColl, Damian J.
    Rhee, Martin S.
    Szwarcberg, Javier
    Cheng, Andrew K.
    Miller, Michael D.
    [J]. ANTIVIRAL THERAPY, 2015, 20 (03) : 317 - 327
  • [6] The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients
    Cassetti, Isabel
    Madruga, Jose Valdez R.
    Suleiman, Jamal Muhamad A. H.
    Etzel, Arnaldo
    Zhong, Lijie
    Cheng, Andrew K.
    Enejosa, Jeffrey
    [J]. HIV CLINICAL TRIALS, 2007, 8 (03): : 164 - 172
  • [7] Efficacy and safety of zidovudine, lamivudine, and tenofovir combination in antiretroviral naive, HIV-1 infected patients
    Rey, D
    Krebs, M
    Partisani, M
    Hess-Kempf, G
    Cheneau, C
    Priester, M
    Bernard-Henry, C
    De Mautort, E
    Lang, JM
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S120 - S120
  • [8] THE SAFETY AND EFFICACY OF TENOFOVIR DF (TDF) IN COMBINATION WITH LAMIVUDINE (3TC) AND EFAVIRENZ (EFV) IN ANTIRETROVIRAL-NAIVE PATIENTS THROUGH SEVEN YEARS
    Carlevari, M.
    Cassetti, I.
    Madruga, J. V. R.
    Etzel, A.
    Suleiman, J.
    Zhou, Y.
    Cheng, A. K.
    Enejosa, J.
    [J]. INFECTION, 2009, 37 : 59 - 59
  • [9] The safety and efficacy of tenofovir DF (TDF) in combination with lamivudine (3TC) and efavirenz (EFV) through 5 years in antiretroviral-naive patients
    Cassetti, I.
    Madruga, J. V. R.
    Suleiman, J. M. A. H.
    Zhong, L.
    Enejosa, J.
    Cheng, A. K.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L50 - L51
  • [10] Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
    Gallant, JE
    Staszewski, S
    Pozniak, AL
    DeJesus, E
    Suleiman, JMAH
    Miller, MD
    Coakley, DF
    Lu, B
    Toole, JJ
    Cheng, AK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02): : 191 - 201
12345